Earlier this year, the American Medical Association’s (AMA) Current Procedural Terminology (CPT) editorial panel established Category I code 87900, described as “infectious agent drug susceptibility phenotype prediction using
Xinhua Finance will give Nutra Pharma strategic advice for advancing its business objectives in China, and help the company to meet potential strategic and operational partners, as well
In the letter, the FDA indicated that at least one additional clinical trial, and a re-read of images obtained in previously completed phase III trials, will be necessary
The decision affirms a lower court decision handed down in March 2005 that immediately halted the sale the generic version by Ranbaxy and Teva, which had launched their
Xyrem was approved by the FDA in October 2002 as a treatment for cataplexy (sudden inability to move) in patients with narcolepsy. The effectiveness of Xyrem for the
New Harbor Corporation (NHC) is to work through PUMC Pharmaceuticals to bring the nitric oxide donor products to market in China that are protected by the Cellegy patent.
Both studies in the clinical program are double-blind randomized, placebo-controlled trials of patients who will receive a brief intravenous infusion of Viprinex or placebo within six hours of
The results show that the drug reduced the primary endpoint of combined incidence of nonfatal myocardial infarction (heart attack) or death through 30 days following coronary artery bypass
The American College of Neuropsychopharmacology (ACNP) produced a so-called Task Force Report evaluating the safety and efficacy of selective serotonin reuptake inhibitor (SSRI) antidepressant medication for depressed youths
The research involved megestrol acetate (marketed as Megace), a synthetic form of the female hormone progesterone. The drug was originally used as an anti-hormonal treatment for breast cancer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.